<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
  <url>
    <loc>https://www.k7comms.com/insights</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-02-26</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/pov-the-narrative-dimension-that-changes-everything</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-02-26</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/trendspotting-a-year-of-healthcare-narratives</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-01-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/a0707446-bcd2-4be5-af07-de722b84330a/2025+signal+scores+-+biotech+sample.png</image:loc>
      <image:title>Insights - Trendspotting a Year of Healthcare Narratives - Make it stand out</image:title>
      <image:caption>Here’s how the biotech Signal Score narratives performed in 2025. Most cluster in the “Clear Signal” range, while only a few broke through as Strong. Learn more about the Signal Score.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/kenvues-narrative-predicament-and-eventual-sale</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-11-05</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/ai-in-healthcare-turning-a-page</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-10-09</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/1949aa97-b44b-495c-b370-64d2f7eb41f4/AIinHealthcare.jpg</image:loc>
      <image:title>Insights - AI in Healthcare: Turning a Page? - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/tylenol-then-and-now-crisis-under-new-ownership</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/0099c67c-b4b6-40da-b609-107ba41ab106/Tylenol+then+now.png</image:loc>
      <image:title>Insights - Tylenol, Then and Now: Crisis Under New Ownership - In 1982, it was a tampering crisis for J&amp;J. In 2025, it’s a crisis of misinformation for Kenvue.</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/glp-1-war-of-the-words-part-ii-the-contenders</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/cc99b16e-f187-4f7b-8d6b-9e4069e5425e/Amgen-Viking_Signal_Score.png</image:loc>
      <image:title>Insights - GLP-1 War of the Words Part II: The Contenders - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/drug-development-is-hard-narrative-resilience-helps-weather-the-storms</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/the-glp-1-narrative-lilly-vs-novo-in-the-war-of-the-words</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-11-02</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/bed5e38a-1bf9-4561-b225-d4930e2217b9/GLP1_Narrative_Signal_Scores.png</image:loc>
      <image:title>Insights - The GLP-1 Narrative: Lilly vs. Novo in the War of the Words - The Signal Score™ diagnostic I scored each product’s narrative across seven dimensions: purpose boldness, problem clarity, point-of-view differentiation, approach credibility, priority focus, stakeholder connection, and commitment strength. Each weighted, totaled to 100.</image:title>
      <image:caption>Learn more about Signal Score™.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/what-sanofis-new-deal-and-boilerplate-say-about-its-strategy</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-29</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/what-a-2b-narrative-looks-like</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-29</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/962c67e8-3eed-46bd-9fa4-67620c8e7787/Capstan+Signal+Score.jpg</image:loc>
      <image:title>Insights - What a $2B Narrative Looks Like - Make it stand out</image:title>
      <image:caption>Capstan’s Signal Score™: Here’s what I found when I assessed Capstan’s narrative earlier this year: the highest score I’ve recorded to date, with clear strengths across narrative dimensions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/the-path-forward</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-08-27</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/the-leadership-disconnect</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-08-27</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/stakeholder-confusion</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-08-27</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/the-healthcare-narrative-problem</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-08-27</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/category/Signal+%3E+Noise</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/tag/Narrative</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/tag/Kimberly+Clark</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.k7comms.com/insights/tag/Kenvue</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.k7comms.com/services</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-03-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/b0af7423-b61a-4398-8261-192d1ac9430d/BUILDsq2.4.JPG</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/8bac9936-633e-4b86-84a2-b5bd62c4b94e/AUDIT_sq2.4.jpg</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/b0af7423-b61a-4398-8261-192d1ac9430d/BUILDsq2.4.JPG</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/e23331f9-af82-497c-8be4-efcf45a8a80a/SIGNALsq2.4.JPG</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2026-03-28</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/da87a2a7-cfe5-43c4-94f2-b0284f69f088/AUDIT.jpg</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/bf125b32-f90d-478a-8ef5-b91114052e6c/BUILD.jpg</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/3c8c9a13-4cf4-42a7-ab58-b9f7d48b2b95/SIGNAL.jpg</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6817a743ee98254b73cfc04f/b0f51004-8e6c-4a6b-90e1-cfd83f8d572c/KF.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.k7comms.com/privacy-policy</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-29</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/terms-of-service</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-29</lastmod>
  </url>
  <url>
    <loc>https://www.k7comms.com/archetypes</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-03-26</lastmod>
  </url>
</urlset>

